what are semaglutide drugs The push for Medicare to cover weight-loss drugs: An explainer Weight-loss jab could be made

Impact: Positive Key areas of impact: Level of evidence: Preliminary Level of risk: Negligible How it works GHK-Cu chelates copper ions, enabling the activation of fibroblasts for more intensive production of collagen and glycosaminoglycans

The glucose-dependent stimulation of insulin secretion means that when blood glucose rises after meals, GLP-1 receptor agonists enhance the pancreatic response, facilitating more efficient glucose uptake by tissues

Obesity Nearly all respondents cover GLP-1s for type 2 diabetes (T2D), versus only 39% who provide coverage for obesity

However, results seem to vary, and more research is needed to validate its effectiveness

Diabetes Ther 12(5):14751489

doi: 10.1016/j.nano.2019.102132